| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/23/2012 | WO2012024452A2 Modified relaxin polypeptides and their uses |
| 02/23/2012 | WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
| 02/23/2012 | WO2012023675A1 Modified nucleotides and real-time polymerase reaction using same |
| 02/23/2012 | WO2012023132A1 Methods of generating oligodendrocytes and cell populations comprising same |
| 02/23/2012 | WO2012022243A1 Kit for quantitatively detecting her2 amplification |
| 02/23/2012 | WO2012021985A1 Oligonucleotide chelate complexes |
| 02/23/2012 | WO2012006732A9 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction |
| 02/23/2012 | WO2011106314A3 Method of making nucleic acid libraries |
| 02/23/2012 | WO2003099989A3 Compositions and methods relating to breast specific genes and proteins |
| 02/23/2012 | WO2003008563A3 Improved cytochrome p450 oxygenases |
| 02/23/2012 | US20120047609 Plant artificial chromosome platforms via telomere truncation |
| 02/23/2012 | US20120047586 Polypeptide having enhanced effector function |
| 02/23/2012 | US20120046456 Method for the producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
| 02/23/2012 | US20120046450 Modulation Of Antibody Effector Function By Hinge Domain Engineering |
| 02/23/2012 | US20120046446 p16 MEDIATED REGULATION OF NMDA RECEPTORS |
| 02/23/2012 | US20120046348 Oligonucleotide chelate complexes |
| 02/23/2012 | US20120046345 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
| 02/23/2012 | US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 02/23/2012 | US20120046343 MULTI-TARGETING SHORT INTERFERING RNAs |
| 02/23/2012 | US20120046342 Oligonucleotide comprising an inosine for treating dmd |
| 02/23/2012 | US20120046339 Novel chorismate mutase gene from the potato cyst nematode globodera rostochiensis |
| 02/23/2012 | US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp |
| 02/23/2012 | US20120046234 Therapeutic compounds |
| 02/23/2012 | US20120046229 Modified relaxin polypeptides and their uses |
| 02/23/2012 | US20120046227 Designer osteogenic proteins |
| 02/23/2012 | US20120046223 Exogenously triggered controlled release materials and uses thereof |
| 02/23/2012 | US20120046221 Albumin fusion proteins |
| 02/23/2012 | US20120046190 Hp1alpha as a prognostic marker in human cancer |
| 02/23/2012 | US20120046175 Methods and systems for solution based sequence enrichment |
| 02/23/2012 | US20120045817 Compositions And Methods Comprising Alpha-Amylase Variants With Altered Properties |
| 02/23/2012 | US20120045813 Gene encoding a protein having an ability to enhance a selenate reduction activity |
| 02/23/2012 | US20120045811 EGVII Endoglucanase and Nucleic Acids Encoding the Same |
| 02/23/2012 | US20120045785 Hybrid Prokaryotic-Eukaryotic Tubulins and Use Thereof |
| 02/23/2012 | US20120045777 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 02/23/2012 | US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 02/23/2012 | US20120045773 Cell adhesion inhibitor and applications thereof |
| 02/23/2012 | US20120045771 Method for analysis of nucleic acid populations |
| 02/23/2012 | US20120045766 Jarid1b for target gene of cancer therapy and diagnosis |
| 02/23/2012 | US20120045753 Sequences diagnostic for shrimp pathogens |
| 02/23/2012 | US20120045465 Cancer antigen helper peptide |
| 02/23/2012 | US20120045464 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 02/23/2012 | US20120045461 Compositions and Methods for Inducing an Immune Response in a Mammal and Methods of Avoiding an Immune Response to Oligonucleotide Agents Such as Short Interfering RNAs |
| 02/23/2012 | US20120045447 T cell costimulating polypeptides and uses thereof |
| 02/23/2012 | US20120045439 Tumor markers and methods of use thereof |
| 02/23/2012 | US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF |
| 02/23/2012 | US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface |
| 02/23/2012 | US20120045425 Delta 4, 5 glycuronidase compositions and methods related thereto |
| 02/23/2012 | US20120045395 MicroRNAs In Idiopathic Pulmonary Fibrosis |
| 02/23/2012 | US20120045391 Formulations Targeting IGFBP7 for Diagnosis and Therapy of Cancer |
| 02/23/2012 | US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor |
| 02/23/2012 | CA2808901A1 Conjugates, particles, compositions, and related methods |
| 02/23/2012 | CA2808596A1 Modified relaxin polypeptides and their uses |
| 02/23/2012 | CA2808372A1 Methods of generating oligodendrocytes and cell populations comprising same |
| 02/23/2012 | CA2807307A1 Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
| 02/23/2012 | CA2806616A1 Oligonucleotide chelate complexes |
| 02/23/2012 | CA2716302A1 Compositions and methods for determining likelihood of an increased susceptibility to contract johne's disease |
| 02/22/2012 | EP2420512A2 Anti-VEGF antibodies |
| 02/22/2012 | EP2419514A1 Plant promoter operable in endosperm and uses thereof |
| 02/22/2012 | EP2419121A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof |
| 02/22/2012 | EP2419110A1 Methods of treating cancers with her3 antisense oligonucleotides |
| 02/22/2012 | EP1791958B1 Yeast/bacterial two-hybrid system and methods of use thereof |
| 02/22/2012 | EP1740608B1 Modified human growth hormone polypeptides and their uses |
| 02/22/2012 | EP1463840B1 Genetic analysis systems and methods |
| 02/22/2012 | EP1364065B1 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 02/22/2012 | CN1913921B 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法 By targeting the apoptotic expose internal antigens of tumor cells to kill tumor cells of the |
| 02/22/2012 | CN102361981A Synthetic RNA-based agonists of TLR7 |
| 02/22/2012 | CN102361882A Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method |
| 02/22/2012 | CN102361881A Methods of producing C4 dicarboxcylic acids |
| 02/22/2012 | CN101353656B 抑制表皮生长因子受体基因表达的siRNA及其应用 Inhibition of epidermal growth factor receptor gene expression and its application siRNA |
| 02/22/2012 | CN101203241B 人源化抗-cd70结合物和其应用 Humanized anti -cd70 conjugates and their application |
| 02/21/2012 | US8119861 Elongase and uses thereof |
| 02/21/2012 | US8119860 Isolated nucleic acid fragments and recombinant constructs; plant cells, transgenic seeds, progeny plants |
| 02/21/2012 | US8119791 si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation |
| 02/21/2012 | US8119789 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 02/21/2012 | US8119787 Molecular tools for manufacturing anti-CD33 antibodies and fragments |
| 02/21/2012 | US8119786 Nucleic acids encoding CCL27 |
| 02/21/2012 | US8119785 Nucleic acid sequences and homologous recombination vectors for distruption of a Fel D I gene |
| 02/21/2012 | US8119784 Delta-4 desaturase and its use in making polyunsaturated fatty acids |
| 02/21/2012 | US8119783 FGF variants and methods for use thereof |
| 02/21/2012 | US8119782 Medium scale integration of molecular logic gates in an automaton |
| 02/21/2012 | US8119781 Luminescent metal ion complexes |
| 02/21/2012 | US8119769 Complement depletion using recombinant human C-3 derivatives |
| 02/21/2012 | US8119766 Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration |
| 02/21/2012 | US8119612 RNAi inhibition of alpha-ENaC expression |
| 02/21/2012 | US8119610 Methods of making RNAi libraries using E. coli RNAse III for inhibition of mammalian gene expression |
| 02/21/2012 | US8119603 Modified human interferon polypeptides and their uses |
| 02/21/2012 | US8119400 Methods of inhibiting smooth muscle cell migration and proliferation |
| 02/21/2012 | US8119383 Glycosidase enzymes |
| 02/21/2012 | US8119380 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 02/21/2012 | US8119369 Human SUMO-3 for enhancing protein expression |
| 02/21/2012 | US8119366 Antennapedia-dominant negative mastermind-like construct |
| 02/21/2012 | US8119364 Methods for generating analogs of coenzyme A |
| 02/21/2012 | US8119359 Methods of indentifying sweet taste modulators |
| 02/21/2012 | US8119349 Methods and materials for detecting mutations in quasispecies having length polymorphisms |
| 02/21/2012 | US8119348 Compositions and methods for diagnosing and treating macular degeneration |
| 02/21/2012 | US8119346 Light emission modifiers and their uses in nucleic acid detection, amplification and analysis |
| 02/21/2012 | US8119343 Method for identifying oculoskeletal dysplasia in dogs |
| 02/21/2012 | US8119341 Genetic variant of the annexin A5 gene |
| 02/21/2012 | US8119340 Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia |
| 02/21/2012 | US8119147 Compositions produced using enteric pathogens and methods of use |